1. Home
  2. ORRF vs DRUG Comparison

ORRF vs DRUG Comparison

Compare ORRF & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orrstown Financial Services Inc

ORRF

Orrstown Financial Services Inc

HOLD

Current Price

$35.01

Market Cap

692.0M

Sector

Finance

ML Signal

HOLD

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

HOLD

Current Price

$70.10

Market Cap

707.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORRF
DRUG
Founded
1919
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Pharmaceuticals and Biotechnology
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
692.0M
707.1M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
ORRF
DRUG
Price
$35.01
$70.10
Analyst Decision
Buy
Strong Buy
Analyst Count
1
5
Target Price
$42.00
$124.00
AVG Volume (30 Days)
157.0K
93.1K
Earning Date
04-21-2026
05-14-2026
Dividend Yield
3.40%
N/A
EPS Growth
182.43
N/A
EPS
4.18
N/A
Revenue
$37,144,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.08
N/A
P/E Ratio
$8.46
N/A
Revenue Growth
36.00
N/A
52 Week Low
$25.57
$23.18
52 Week High
$40.72
$123.75

Technical Indicators

Market Signals
Indicator
ORRF
DRUG
Relative Strength Index (RSI) 44.77 39.49
Support Level $34.51 $49.47
Resistance Level $35.28 $84.29
Average True Range (ATR) 0.99 3.95
MACD 0.13 -0.06
Stochastic Oscillator 59.17 9.69

Price Performance

Historical Comparison
ORRF
DRUG

About ORRF Orrstown Financial Services Inc

Orrstown Financial Services Inc is a financial holding company. Through its subsidiaries, it operates in the community banking segment and engages in lending activities, including commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending and deposit services, including checking, savings, time, and money market deposits. The Group also provides fiduciary, investment advisory, insurance, and brokerage services. It offers services to individuals, professionals, small businesses, and other enterprises across different locations in the United States through its branch network and client service centers.

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Share on Social Networks: